BRIEF-GlaxoSmithKline CEO says Nov R&D day will be "key moment" for company
July 29, 2015 at 07:44 AM EDT
July 29 (Reuters) - GlaxoSmithKline Plc CEO Andrew Witty told reporters: * CEO says research and development event in November will be "key moment" for